Concepedia

Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study

Christopher D. Buckley, Jesus Abraham Simón Campos, Brandon Becker, Katherine Davy, Elena Fisheleva, Anubha Gupta, Carol Hawkes, David R. Inman, Mark Layton, Nina Mitchell,

The Lancet Rheumatology · 2020 · 44 citations · 18 references

DOIFull text

Open access

Concepts

References

18

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

Daniel Aletaha, Tuhina Neogi, Alan J. Silman et al. · Arthritis & Rheumatism · 2010 · 9.6K citations · Full text

, , +13

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

Catriona Grigor, Hilary A. Capell, A. Stirling et al. · The Lancet · 2004 · 1.4K citations

, , +5

Distinct fibroblast subsets drive inflammation and damage in arthritis

Adam P. Croft, Joana Campos, Kathrin Jansen et al. · Nature · 2019 · 954 citations · Full text

, , +12

The american college of rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

Marc C. Hochberg, Rowland W. Chang, Isaac L. Dwosh et al. · Arthritis & Rheumatism · 1992 · 886 citations

, , +12

Double‐blind randomized controlled clinical trial of the interleukin‐6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

Ravinder N. Maini, Peter C. Taylor, Jacek Szechiński et al. · Arthritis & Rheumatism · 2006 · 792 citations

, , +17